J R Anderson
About
J R Anderson is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, J R Anderson has authored 50 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 24 papers in Pathology and Forensic Medicine and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J R Anderson's work include Lymphoma Diagnosis and Treatment (22 papers), Sarcoma Diagnosis and Treatment (12 papers) and Viral-associated cancers and disorders (11 papers). J R Anderson is often cited by papers focused on Lymphoma Diagnosis and Treatment (22 papers), Sarcoma Diagnosis and Treatment (12 papers) and Viral-associated cancers and disorders (11 papers). J R Anderson collaborates with scholars based in United States, United Kingdom and Australia. J R Anderson's co-authors include Robert B. Davis, Kevin C. Cain, RD Gelber, Philip J. Bierman, Anne Kessinger, Julie M. Vose, Michael Bishop, Jamés O. Armitage, J. M. Vose and J. O. Armitage and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.
In The Last Decade
J R Anderson
50 papers receiving 3.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| J R Anderson United States | 27 | 1.6k | 1.5k | 1.1k | 700 | 666 | 50 | 3.9k | ||
| Ralph M. Meyer Canada | 36 | 1.7k 1.1× | 1.8k 1.2× | 827 0.7× | 1.5k 2.1× | 730 1.1× | 139 | 4.7k | ||
| H Brincker Denmark | 32 | 1.3k 0.8× | 1.0k 0.7× | 1.0k 0.9× | 372 0.5× | 312 0.5× | 93 | 3.4k | ||
| Arthur T. Skarin United States | 39 | 2.7k 1.7× | 1.2k 0.8× | 2.4k 2.2× | 314 0.4× | 568 0.9× | 122 | 5.4k | ||
| Georges Fillet Belgium | 37 | 1.4k 0.8× | 2.1k 1.5× | 865 0.8× | 2.0k 2.8× | 1.4k 2.1× | 151 | 5.3k | ||
| Patrice Carde France | 39 | 1.6k 1.0× | 2.8k 1.9× | 1.4k 1.3× | 177 0.3× | 706 1.1× | 152 | 4.3k | ||
| Ester Orlandi Italy | 35 | 1.3k 0.8× | 784 0.5× | 1.1k 1.0× | 374 0.5× | 802 1.2× | 241 | 4.0k | ||
| Maurice Tubiana France | 28 | 2.4k 1.5× | 3.4k 2.3× | 1.4k 1.2× | 225 0.3× | 961 1.4× | 83 | 6.5k | ||
| Ulrich Mey Germany | 25 | 1.5k 0.9× | 1.0k 0.7× | 416 0.4× | 854 1.2× | 769 1.2× | 68 | 2.9k | ||
| Dirk Hasenclever Germany | 41 | 2.5k 1.6× | 3.9k 2.6× | 1.3k 1.2× | 628 0.9× | 1.0k 1.5× | 128 | 5.9k | ||
| Howard J. Weinstein United States | 43 | 1.2k 0.8× | 1.4k 0.9× | 794 0.7× | 2.2k 3.1× | 694 1.0× | 122 | 5.4k |
Countries citing papers authored by J R Anderson
Since
Specialization
Citations
This map shows the geographic impact of J R Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J R Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J R Anderson more than expected).
Fields of papers citing papers by J R Anderson
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by J R Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J R Anderson. The network helps show where J R Anderson may publish in the future.
Co-authorship network of co-authors of J R Anderson
This figure shows the co-authorship network connecting the top 25 collaborators of J R Anderson. A scholar is included among the top collaborators of J R Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J R Anderson. J R Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fresneau, Brice, Allan Hackshaw, Douglas S. Hawkins, et al.. (2017). Investigating the heterogeneity of alkylating agents’ efficacy and toxicity between sexes: A systematic review and meta‐analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study). Pediatric Blood & Cancer. 64(8).
2.
Ermoian, Ralph P., John C. Breneman, David Walterhouse, et al.. (2016). Is 45 Gy a Sufficient Radiation Therapy Dose for Unresected Orbital Embryonal Rhabdomyosarcoma? A Report From the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. International Journal of Radiation Oncology*Biology*Physics. 96(2). E548–E548.
3.
Merks, Johannes H. M., Gian Luca De Salvo, Christophe Bergeron, et al.. (2013). Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups. Annals of Oncology. 25(1). 231–236.
4.
Lin, Chi, Sarah S. Donaldson, Jane L. Meza, et al.. (2010). The Effect of Radiation Therapy Techniques (IMRT vs. 3DCRT) on Outcome in Patients with Intermediate Risk Rhabdomyosarcoma Enrolled in COG D9803: A Report from COG. International Journal of Radiation Oncology*Biology*Physics. 78(3). S21–S22.
5.
Rupp, Mark E., et al.. (2007). Outbreak of Bloodstream Infection Temporally Associated with the Use of an Intravascular Needleless Valve. Clinical Infectious Diseases. 44(11). 1408–1414.
6.
Breneman, John C., J R Anderson, Sarah S. Donaldson, et al.. (2001). Prognostic factors and outcome in children with metastatic rhabdomyosarcoma - a report from the intergroup rhabdomyosarcoma study IV. International Journal of Radiation Oncology*Biology*Physics. 51(3). 118–118.
7.
Hauke, Ralph J., Bassam N. Smir, Timothy C. Greiner, et al.. (2001). Clinical and pathological features of posttransplant lymphoproliferative disorders: Influence on survival and response to treatment. Annals of Oncology. 12(6). 831–834.
8.
Haluska, Brian, Colin Case, Leanne Short, J R Anderson, & Thomas H. Marwick. (2001). Effect of power Doppler and digital subtraction techniques on the comparison of myocardial contrast echocardiography with SPECT. Heart. 85(5). 549–555.
9.
Kessinger, Anne, P. J. Bierman, Mary Kathryn Cowles, et al.. (1998). Mobilized versus non-mobilized peripheral stem cell transplantation after high dose therapy for low grade nonhodgkin lymphoma: Effect on failure-free survival. 5(2). 113–119.
10.
Bierman, Philip J., Julie M. Vose, J R Anderson, et al.. (1997). High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 15(2). 445–450.
11.
Bobrowski, Walter F., et al.. (1996). Malignant Intracranial Teratoma in a Juvenile Wistar Rat. Veterinary Pathology. 33(4). 462–465.
12.
Vose, J. M., J Anderson, P. J. Bierman, et al.. (1996). Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy.. Journal of Clinical Oncology. 14(2). 520–526.
13.
Martín‐Algarra, Salvador, Michael R. Bishop, Stefano Tarantolo, et al.. (1995). Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.. Deposito Adademico Digital Universidad De Navarra (University of Navarra). 23(14). 1503–8.
14.
Bennett, C. L., JO Armitage, Julie M. Vose, et al.. (1995). Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991.. Journal of Clinical Oncology. 13(4). 969–973.
15.
Darrington, Deborah L., Julie M. Vose, J R Anderson, et al.. (1994). Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.. Journal of Clinical Oncology. 12(12). 2527–2534.
16.
Vose, J. M., J R Anderson, Anne Kessinger, et al.. (1993). High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 11(10). 1846–1851.
17.
Vose, J. M., Elizabeth Reed, J R Anderson, et al.. (1993). Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.. Journal of Clinical Oncology. 11(7). 1306–1310.
18.
Anderson, J R, R. D. T. Jenkin, John F. Wilson, et al.. (1993). Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group.. Journal of Clinical Oncology. 11(6). 1024–1032.
19.
Sanger, WG, et al.. (1990). Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group. Blood. 75(9). 1841–1847.
20.
Wilkinson, Iain, et al.. (1987). Oligodendroglioma: an analysis of 42 cases.. Journal of Neurology Neurosurgery & Psychiatry. 50(3). 304–312.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ralph M. Meyer Breakdown of academic impact, for papers by H Brincker Breakdown of academic impact, for papers by Arthur T. Skarin Breakdown of academic impact, for papers by Georges Fillet Breakdown of academic impact, for papers by Patrice Carde Breakdown of academic impact, for papers by Ester Orlandi Breakdown of academic impact, for papers by Maurice Tubiana Breakdown of academic impact, for papers by Ulrich Mey Breakdown of academic impact, for papers by Dirk Hasenclever Breakdown of academic impact, for papers by Howard J. Weinstein